[go: up one dir, main page]

ATE455307T1 - Verfahren zur verwendung von cest-kontrastmitteln bei der magnetresonanztomographie - Google Patents

Verfahren zur verwendung von cest-kontrastmitteln bei der magnetresonanztomographie

Info

Publication number
ATE455307T1
ATE455307T1 AT06727996T AT06727996T ATE455307T1 AT E455307 T1 ATE455307 T1 AT E455307T1 AT 06727996 T AT06727996 T AT 06727996T AT 06727996 T AT06727996 T AT 06727996T AT E455307 T1 ATE455307 T1 AT E455307T1
Authority
AT
Austria
Prior art keywords
magnetic resonance
contrast agents
resonance tomography
cest contrast
contrast agent
Prior art date
Application number
AT06727996T
Other languages
English (en)
Inventor
Rene Wegh
Jeroen Pikkemaat
Nicolaas Willard
Original Assignee
Koninkl Philips Electronics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninkl Philips Electronics Nv filed Critical Koninkl Philips Electronics Nv
Application granted granted Critical
Publication of ATE455307T1 publication Critical patent/ATE455307T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/4804—Spatially selective measurement of temperature or pH

Landscapes

  • Physics & Mathematics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Signal Processing (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06727996T 2005-04-26 2006-04-21 Verfahren zur verwendung von cest-kontrastmitteln bei der magnetresonanztomographie ATE455307T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05103355 2005-04-26
PCT/IB2006/051237 WO2006114739A2 (en) 2005-04-26 2006-04-21 Method for using cest contrast agents in mri

Publications (1)

Publication Number Publication Date
ATE455307T1 true ATE455307T1 (de) 2010-01-15

Family

ID=37215131

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06727996T ATE455307T1 (de) 2005-04-26 2006-04-21 Verfahren zur verwendung von cest-kontrastmitteln bei der magnetresonanztomographie

Country Status (6)

Country Link
US (1) US7917188B2 (de)
EP (1) EP1889086B1 (de)
CN (1) CN101166987B (de)
AT (1) ATE455307T1 (de)
DE (1) DE602006011736D1 (de)
WO (1) WO2006114739A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7610077B2 (en) * 2005-12-08 2009-10-27 General Electric Compnay Quantitation of sample properties using contrast enhancement from saturation transfer
EP2035044B1 (de) 2006-06-09 2013-10-16 Koninklijke Philips N.V. Eliminierung der kontrastmittelkonzentrationsabhängigkeit in der kernspintomographie
EP2199815A1 (de) * 2008-12-22 2010-06-23 Koninklijke Philips Electronics N.V. MR-Bildgebung mit CEST-Kontrastverstärkung
CA2791278C (en) 2010-02-25 2015-11-24 The Johns Hopkins University Sustained delivery of therapeutic agents to an eye compartment
US9157976B2 (en) * 2010-07-20 2015-10-13 The Trustees Of The University Of Pennsylvania CEST MRI methods for imaging glutaminolysis in cancer
WO2012109363A2 (en) 2011-02-08 2012-08-16 The Johns Hopkins University Mucus penetrating gene carriers
EP2515138A1 (de) * 2011-04-19 2012-10-24 Koninklijke Philips Electronics N.V. Bewegungsausgelöste Magnetresonanzbildgebung mit APT/CEST
DE102011078680B3 (de) * 2011-07-05 2012-12-20 Siemens Aktiengesellschaft Magnetfeldunempfindliche CEST-Bildgebung
WO2014124006A1 (en) * 2013-02-05 2014-08-14 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
WO2015175545A1 (en) 2014-05-12 2015-11-19 The Johns Hopkins University Highly stable biodegradable gene vector platforms for overcoming biological barriers
US10485757B2 (en) 2015-01-27 2019-11-26 The Johns Hopkins University Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
JP6964583B2 (ja) * 2015-12-23 2021-11-10 ブラッコ・イメージング・ソシエタ・ペル・アチオニBracco Imaging S.P.A. レシオメトリックパルスｃｅｓｔイメージング
CN105759233B (zh) * 2016-03-04 2018-09-25 深圳先进技术研究院 一种快速化学交换饱和转移成像方法和系统
US20240036134A1 (en) * 2022-07-26 2024-02-01 Canon Medical Systems Corporation pH CALCULATING APPARATUS, MAGNETIC RESONANCE IMAGING APPARATUS, AND pH CALCULATING METHOD

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6746662B1 (en) * 1999-02-09 2004-06-08 Board Of Regents The University Of Texas System pH sensitive MRI contrast agents
WO2000066180A2 (en) * 1999-04-21 2000-11-09 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health Method for enhancing contrast produced by mri
EP1390079A2 (de) * 2000-11-20 2004-02-25 Board of Regents University of Texas System Paramagnetischen metallion-basierte makrozyklische kontrastmitteln
AU2002364728A1 (en) * 2001-12-13 2003-06-23 The Johns Hopkins University School Of Medicine Method for mr/nmr imaging
EP2269659A1 (de) * 2002-01-24 2011-01-05 Barnes Jewish Hospital Integrin-targeted Kontrastmittel
EP1331012A1 (de) 2002-01-29 2003-07-30 BRACCO IMAGING S.p.A. Magnetisch beeinflussbare paramagnetische Kontrastmittel für Magnetresonanzbildgebung
JP4355144B2 (ja) 2003-01-21 2009-10-28 学校法人日本大学 新規含窒素環状化合物

Also Published As

Publication number Publication date
WO2006114739A3 (en) 2007-07-12
EP1889086A2 (de) 2008-02-20
US7917188B2 (en) 2011-03-29
DE602006011736D1 (de) 2010-03-04
CN101166987A (zh) 2008-04-23
WO2006114739A2 (en) 2006-11-02
US20080188738A1 (en) 2008-08-07
EP1889086B1 (de) 2010-01-13
CN101166987B (zh) 2011-01-12

Similar Documents

Publication Publication Date Title
ATE455307T1 (de) Verfahren zur verwendung von cest-kontrastmitteln bei der magnetresonanztomographie
DE602006005348D1 (de) Abbildung der elastizität der lunge durch magnetische resonanz-elastographie
ATE439866T1 (de) Kontrastmittel für die magnetresonanzbildgebung mit cest-aktivem paramagnetischem komplex
DE602004012079D1 (de) Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung
DE60319475D1 (de) Parallele Magnetresonanzbildgebung unter Verwendung von Navigator-Echosignalen
ATE533502T1 (de) Verfahren zur modulation der il-23-aktivität; relevante reagenzien
DE602004017170D1 (de) Mit öffnungen versehene abrichtescheibe verwendendes verfahren
DE602006002073D1 (de) Supraleitender Magnet für Kerspintomographie
DE602005013819D1 (de) Pyridincarbonsäureamidderivate zur verwendung als antikrebsmittel
ATE260272T1 (de) Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren
WO2007146941A3 (en) Version compliance system
ATE519505T1 (de) Reaktive paramagnetische kontrastmittel für magnetresonanzbildgebung
DE60233743D1 (de) Verfahren zur verwendung von quantitativen lipidmetabolondaten
DE602006014106D1 (de) Verfahren zur diagnose von prostatakrebs
ATE548030T1 (de) Zusammensetzung mit langsamer freisetzung von fe salzen, verfahren zu ihrer herstellung und ihre verwendung
WO2006086343A3 (en) Chemical exchange saturation transfer based mri using reporter genes and mri methods related thereto
DE602006009513D1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
DE60225903D1 (de) In-vivo verfahren zur messung von auf der haut oder dessen komponenten bindenden aktiven chemischen substanzen
WO2014197419A8 (en) A MULTI-ECHO LENGTH AND OFFSET VARIED SATURATION (Me-LOVARS) METHOD FOR CHEMICAL EXCHANGE SATURATION TRANSFER (CEST) MR IMAGING
DE60135130D1 (de) Verwendung von substituierten pyrazolen zur behandlung von allergien
WO2005012901A3 (en) Method for measuring aromatase activity
ATE544474T1 (de) Magnetresonanz-abbildungsmittel, abbildungsmedium und verfahren zur abbildung, worin solch ein abbildungsmedium verwendet wird
AU2003253331A1 (en) Measurement of the macromolecular proton density involved in magnetization transfer by means of magnetic resonance
ATE443529T1 (de) Kontrastmittel für die magnetresonanztomographie
DE60329861D1 (de) Neue, auf der antigen-antikörper-reaktion beruhende sondenplatte sowie reagenzienkit und verfahren mit verwendung der sondenplatte

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties